CONFERENCE: Computers in cancer management

Preview:

Citation preview

428

Computers in cancer management

The National Library of Medicine atBethesda, Maryland, USA, was thevenue for a futuristic look at ComputerApplications for Early Detection andStaging of Cancer. Organised by theEarly Detection Branch of the

National Cancer Institute, the meet-ing was attended by a widely variedgroup of 70 people with medical andscientific backgrounds who came to-gether on July 29-30 to listen to and todiscuss 26 presentations.The three themes were radiological

image enhancements, laboratory dataanalysis, and cancer staging. Althoughcontroversial, the development ofneural network computer analysismethods (of which there are severaldifferent types) seems to be producingthe means by which complex constell-ations of information can be arrangedand rearranged by a process of "net-work training" such that the resultant"conclusion" has value for clinical

decision-making. The backgroundwas well described by W G Baxt(University of California, San DiegoMedical Center), whose abstract in theconference programme provided auseful list of references. The use ofartificial neural networks for advancedpattern recognition goes back over 25years but progress was delayed by thediscovery that single-layer neural net-works could not solve even the mostbasic non-linear problems. The multi-layer network has, however, beenshown to be a potent aid to the analysisof complex problems. It has been

applied widely to clinical medicine,especially over the past two years. Ithas been used to detect aromas, and tosimulate somatosensory systems andcolour vision. Networks have beenused to analyse a wide range of

imaging data (eg, thermal images, :magnetic resonance scans, radio-

graphs, ultrasound images), and wave-form data (eg, electrocardiograms,electroencephograms, arterial pres-sure wave-forms), cytological find-

ings, and pharmacokinetic propertiesof drugs. The ability of artificial neuralnetworks to perform accurately evenwhen provided with partly inaccurateraw data, makes them valuable forclinical diagnosis. They have beenapplied fairly successfully to the diag-nosis of skin lesions, appendicitis, v

prediction of the onset of diabetes

mellitus, back pain, and dementia, andthe analysis of anterior chest pain.

The basic objectives in using neuralnetworks for analysis of radiologicalimaging and laboratory data are notonly to enhance the quality of theinformation but also to study therelation within the data such that the

sensitivity, specificity, and positivepredictive value of the resultant con-clusion can be identified and be used asa basis for improved management. Bycontrast, the potential of neural net-works for predicting outcome oftreatment for a particular patient orgroup of patients on the basis of

prognostic factors has not yet beenrealised. Furthermore, the prognosisfor patients with intermediate stagecancer as defined by the TNM system(ie, stages II and III) cannot be pre-dicted reliably. Hence the AmericanJoint Committee on Cancer (AJCC)has recently committed itself to thestudy of new systems for derivingmore accurate predictions of outcome.The discussion at this meeting con-cluded that neural networks are

worthy of study in regard to therefinement of staging systems for pre-dicting outcome from analysis of

multiple factors. However, many

problems remain with the use of neu-ral networks or the more classic statis-

tically based approach to the predic-tion of outcome (Cox regression andBayes’ probabilistic theorem): the

management of censored data, in-

formation scaling, mixed data types,and missing and "messy" data are

examples of the issues that need to becritically analysed for all predictivemethods. A most challenging subjectis the possibility that some prognosticfactors have different effects on out-come depending on the time vector ofthe estimation. For example, a factormay have a strong influence on out-come for the first two years, and thenits effect may disappear while otherstake over in prognostic weight. Thisinconsistent effect on prognosis iscalled "non-monotonicity" and it

represents a methodological challengefor all prognosticsystems.

Although this meeting was at timessomewhat disjointed, it represented animportant milestone in theadvancement of medical information

systems that we will all be using soon.The exploitation of neural networks islikely to play an important part in the

: developments.

L Peter Fielding

Hitch in tobacco andalcohol advertising banMoscow City Council last month passed atotal ban on tobacco and alcohol advertis-

ing. The snap decision led to an outcry, notonly from Moscow’s new advertising agen-cies but also from legal experts, for Russia’snew laws on entrepreneurial activities allowbusinesses to engage in any activities otherthan those specifically prohibited by law.And Moscow, being only a "region" withinthe Russian Federation, cannot issue itsown laws. The City Council is empoweredto issue local ordinances, but these must notcontravene federal legislation. :

In a draft "Municipal Programme",Moscow City Council had envisaged banson tobacco and alcohol advertisements inspecific locations, restrictions on adver-tisement size, and a surcharge on advertis-ing fees for these products. Last month’sdecision, however, envisaged a total ban notonly on the products, but also on all othergoods marketed under the same namepublicity for foodstuffs produced by atobacco company is good publicity for itscigarettes. :

The advertising agencies hint that thenew ruling was prompted not so much outof concern for public health but as a form ofreprisal for not responding to the City’srequest to the business community to raise3 million roubles for holidays for childrenwith alcoholic parents.A Moscow ban will reach far outside the

City limits, since most of Russia’s nationalnewspapers and the main TV channels

originate in Moscow. Foreign newspapers,also, will be affected, but it is difficult to seehow such a ban could be implemented.

Russian federal law is, in fact, slowlymoving towards a ban on tobacco andalcohol advertising in the media. Such aban is envisaged in the new "Fundamentalsof Legislation on Public Health", whichrecently passed their second reading in

Parliament. But, as currently worded, theban would apply to a product, not to afirm’s name. Penalties for offenders, it issaid, will be embodied in a future amend-ment to the existing Mass Media Law, andin a projected Law on Advertising. Mean-while, in Moscow, cigarette posters are dueto come down this month.

Vera Rich

Recommended